研室 100 Low expression High expression 80 20 P=0.029 0 4060 % OS(months) Fig.3 NCAPG2表达与肺癌患者总生存期的相关性 11
11 Fig. 3 NCAPG2 表达与肺癌患者总生存期的相关性 生物化学与分子生物学教研室
Table3 NCAPG2表达可独立作为肺癌患者预后指标 Table 3 Multivariate analyses of NCAPG2 protein expression and other clinical prognostic factors in lung adenocarcinoma patients Over survival Factors HR (95%CI),P Age(>65/<65 years) 0.752(0.466-1.571),0.235 Gender(Femle/Male) 1.461(0.845-2.526),0.453 Size of tumour (>3 cm/<3 cm) 1.321(0.745-1.972),0.202 N stage (N1-3/NO) 1.591(1.205-2.829),0.036 p-TNM Stage(Il+versus I) 1.573(1.261-2.671),0.034* NCAPG2 expression(high/low) 2.107(1.361-3.37),0.028 *P<0.05.HR:hazard ration;95%Cl:95%confidence interval. 12
12 Table 3 NCAPG2表达可独立作为肺癌患者预后指标 生物化学与分子生物学教研室
14 NCAPG2 02 . H1299 s.1 A549 s-1 Fig.4 NCAPG2沉默抑制肺癌细胞增殖和克隆形成 13
13 Fig. 4 NCAPG2 沉默抑制肺癌细胞增殖和克隆形成 生物化学与分子生物学教研室
AS49 51 NCAPG2 CB】 l-octin G2M 4549 NCAPG2 Cdc2 Cydin B1 P2 P21 Fig.5 NCAPG2沉默诱导细胞周期阻滞 14
14 Fig. 5 NCAPG2 沉默诱导细胞周期阻滞 生物化学与分子生物学教研室
A NCAPG2 high expression B PLK1 high expression 10 r=0.791.P<0.001 01 09 H1915 703 6 PLK1 0 β-actin 6912 15 NCAPG2 expression Fig.6 NCAPG2与靶基因PLK1表达正相关 15
15 Fig. 6 NCAPG2 与靶基因PLK1表达正相关 生物化学与分子生物学教研室